A Long-Term Safety and Efficacy Study of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea



Status:Completed
Conditions:Cosmetic, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:April 2014
End Date:September 2015

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

This study will evaluate the long-term safety and efficacy of AGN-199201 in patients with
persistent erythema associated with rosacea.


Inclusion Criteria:

-Moderate to severe persistent facial erythema associated with rosacea.

Exclusion Criteria:

- Current treatment with monoamine oxidase (MAO) inhibitors

- Raynaud's syndrome, narrow angle glaucoma, orthostatic hypotension, scleroderma or
Sjogren's syndrome.
We found this trial at
1
site
Clinical Trial Facility in Portland Oregon
Portland, Oregon
?
mi
from
Portland, OR
Click here to add this to my saved trials